Prisys is a Shanghai-based nonhuman primate pharmacology CRO, pioneered NHP models covering a number of disease areas, including immunology (inflammation and autoimmunity), cardiovascula, cerebrovascula, hematology, hepatology, nephrology, pulmonology, OB-GYN, and oncology, to provide pharmacology studies for new medicines in nonclinical or preclinical phase, with human translatable endpoints.
» Top New Products
Loading the page...
Prisys established the unique NHP pharmacology platform by successful integration of its proprietary NHP disease modeling expertise and rich pharmacology experience with well-organized local monkey resources and top-equipped clinical hospitals, enabling global pharmaceuticals to access monkey studies in the way of both environmental and cost effectiveness. Prisys welcomes flexible, broad and dedicated collaborations worldwide for quick establishment and/or co-development of disease models, technologies and exploratory studies targeting at the specific interests in translational NHP pharmacology to the human applications.
For general information：firstname.lastname@example.org
For business collaboration：email@example.com
For job opportunities：firstname.lastname@example.org